Cite
Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective.
MLA
Arlett, Peter, et al. “Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective.” Pharmaceutical Medicine, vol. 28, no. 6, Dec. 2014, pp. 309–15. EBSCOhost, https://doi.org/10.1007/s40290-014-0071-5.
APA
Arlett, P., Postigo, R., Janssen, H., & Spooner, A. (2014). Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective. Pharmaceutical Medicine, 28(6), 309–315. https://doi.org/10.1007/s40290-014-0071-5
Chicago
Arlett, Peter, Rodrigo Postigo, Heidi Janssen, and Almath Spooner. 2014. “Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective.” Pharmaceutical Medicine 28 (6): 309–15. doi:10.1007/s40290-014-0071-5.